跳至主要内容

Green Synthesis Concept in Organic Synthetic Chemistry

 Organic synthetic chemistry is the core course of applied chemistry, chemistry, chemical engineering, and other majors. Organic synthetic chemistry involves a wide range of knowledge and rich content, covering all unit reactions and the formation and transformation of chemical bonds.

Medicilon can undertake the synthesis of special reagents, intermediates and molecular fragments, preparation of standard products, synthesis design and preparation of impurities or metabolites, synthesis of stable isotope internal standards and synthesis of tritiated compounds.

Green chemistry is an emerging discipline, covering many disciplines such as chemistry, materials, biology, pharmacy, environment, etc. It has clear social needs and scientific goals. According to reasonable reaction mechanisms and methods, it can reduce or eliminate the impact of the chemical industry on the environment from the source. To ensure that the reagents, catalysts, solvents, by-products, products, and other links meet the requirements of green and environmental protection, the main goal of organic synthesis at present [2]. For the synthesis of organic compounds, the main factors affecting the yield include synthesis technology, chemical reaction, reaction reagent, reaction solvent, catalyst, etc. Osmosis in Chemistry.

Related Articles:

Medicilon Drug Discovery - Chemistry Department

Join Medicilon at BOSS XVII 17th Belgian Organic Synthesis Symposium

Preparation Method and Related Synthesis Process of Chiral Drug

1 Green synthesis technology

The traditional organic synthesis reaction is a liquid phase reaction under the action of a solvent, which not only has a high reaction temperature, long reaction time, and low reaction efficiency and causes environmental pollution due to organic solvents. Therefore, since the 21st century, green synthesis Methods have been deeply researched and developed, such as solid-phase synthesis, solvent-free synthesis, microwave-assisted, ultrasonic-assisted technology, photochemical synthesis, electrochemical synthesis, and other technologies. These technologies can greatly shorten the reaction time and increase the reaction yield; reducing cost and pollution and improving efficiency are important ways to realize green organic synthesis.



2 Greening Reaction

In the synthesis of organic compounds, under the premise of green chemistry, improving the yield and reaction efficiency is the ultimate goal

3 Green Reagents

"A clever woman cannot cook without rice." Hence, in the unit reaction of organic synthesis, the reaction reagents, the raw materials, are indispensable factors and one of the important influencing factors. The choice of reaction reagents directly affects the success or failure of the unit reaction and the effect. Selecting suitable reaction reagents is important for preventing or reducing pollution from the source and achieving green reactions.

4 Greening solvents

In the unit reaction of organic synthesis, the liquid phase reaction has always been the main synthesis process, so the solvent is one of the important influencing factors, and its structure, type, dosage, etc., will affect the effect of the reaction. In organic reactions, solvation and solvolysis exist between solvent and solute, so different reaction solvents may have different reaction mechanisms; different solvents may have different reaction selectivity. Traditional liquid-phase organic reactions often use halogenated hydrocarbons and benzene aromatic hydrocarbons as solvents. However, most of these substances are volatile, toxic, harmful, and difficult to recycle or degrade, so they are discharged into the environment during use or after the reaction. It can cause serious harm to humans and the environment.

5 Greening Catalysts

The role of the catalyst is to increase or decrease the organic reaction, and it is also one of the important factors affecting the organic synthesis reaction. Its type and amount directly affect the yield of the reaction. The role of catalysts in organic reactions is to participate in the synthesis of reaction intermediates and not to participate in the synthesis of products to achieve the purpose of catalytic reactions. Therefore, many catalysts can realize, improve atom economy, speed up reaction rate and increase conversion rate, and improve The selectivity of a chemical reaction is directly related to the success or failure of the reaction.

评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati